Clinical Trial Update: Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled carbon monoxide to modify chronic inflammation in patients with stable COPD. The trial status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled carbon monoxide (carbon monoxide inhalation)

Snippet

Sponsor: Groningen Research Institute for Asthma and COPD | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED